94718 ⎘
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms Eight-membered rings
NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF
#2DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF
#3REVERSIBLE DPP1 INHIBITORS AND USES THEREOF
#4NEFOPAM DOSAGE FORMS AND METHODS OF TREATMENT
#5Nefopam dosage forms and methods of treatment
#6Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
#715-PGDH INHIBITOR
#8NEFOPAM DOSAGE FORMS AND METHODS OF TREATMENT
#9Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
#10Nefopam dosage forms and methods of treatment
#11Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
#12Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
#13Azocane and azonane derivatives and methods of treating hepatitis B infections
#14Azocane and azonane derivatives and methods of treating hepatitis B infections
#15Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
#16Compounds and methods for treating autoimmune diseases
#17Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease
#184-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases
#19Heat shock protein 90 inhibitors
#20Benzoxazocines and Their Therapeutic Use
#21Tetracyclic indole derivatives as antiviral agents
#22COUPLING METHOD BETWEEN INTRAMOLECULAR CARBON IN UNSATURATED HYDROCARBON COMPOUND USING ORGANO-INDIUM COMPOUND AS COUPLING AGENT
#23Process for the resolution of nefopam
#24Heat shock protein 90 inhibitors
#25Heterocyclylakylamines as muscarinic receptor antagonists
#26Method of purifying macrolides
#27Method of purifying tacrolimus
#28Tetracyclic indole derivatives as antiviral agents
#29Heat shock protein 90 inhibitors
#30Novel benzoxazocines and their therapeutic use
#31Compounds
#32Nefopam dosage forms and methods of treatment